DHMH continues to urge people who have new or worsening symptoms, including symptoms of meningitis or stroke, following an injection of methylprednisolone acetate from one of the seven Maryland facilities that received the implicated NECC lots to contact their healthcare provider to determine if further evaluation is indicated.